-
Haitian International's revenue in the first half of the year fell by 14.78
Time of Update: 2022-08-18
6% over the same period last year In response to the company's business development strategy and the needs of market industry upgrading and upgrading, the Zhafir Electric series achieved sales of RMB 773 million in the first half of 2019, an increase of 13.
-
If I have diabetes, what should I check other than blood sugar
Time of Update: 2022-08-15
In the presence of paresthesias, foot ulcers, or amputation, examinations are recommended at each visit; ➤ Type 2 diabetes: examinations at diagnosis, then yearly .
In the presence of paresthesias, foot ulcers, or amputation, examinations are recommended at each visit; ➤ Type 2 diabetes: examinations at diagnosis, then yearly .
-
A number of innovative drug companies have achieved outstanding commercialization performance, and sales revenue has grown strongly
Time of Update: 2022-04-18
It is reported that due to the continuous growth of research and development expenses, Junshi Bio's operating income cannot cover the growing research and development expenses and other expenses, resulting in the company not yet achieving profitability in 2021 .
-
Rapid detection technology of malachite green and crystal violet in aquatic products (rapid box method
Time of Update: 2022-03-16
Remove the extractant and drop it on the white spotting plate to form a green or purple ring spot on the plate, which can accurately determine whether the sample contains malachite green or crystal violet .
-
Pfizer submitted an emergency authorization application for oral new crown drugs and agreed to other companies' production. CDMO will win Calaiying
Time of Update: 2021-12-06
If authorized or approved, this oral drug is particularly suitable for low-income and middle-income countries, and can play a key role in saving lives and contribute to the global fight against the new crown epidemic," MPP Executive Director Charles Gore (Charles Gore) added, "We will work with generic drug companies to make the combination therapy of PF-07321332 and the HIV drug ritonavir, which can provide patients with sufficient supply .
-
Pantoprazole Sodium for Injection, a wholly-owned subsidiary of Sialon Pharmaceuticals, passed the consistency evaluation of generic drugs
Time of Update: 2021-11-05
On September 8, Sialon Pharmaceutical issued an announcement stating that its wholly-owned subsidiary, Hunan Sialon Pharmaceutical, had recently obtained the "Approval Notice for Supplementary Drug Ap
-
Sales of large varieties soared by 1300%, Qilu first imitated listing
Time of Update: 2021-10-21
The only domestic company that has a layout to imitate ceftazidime and Avibactam sodium for injection, Qilu Pharmaceutical may quickly occupy the market 01.
The launch of Qilu Pharmaceutical's ceftazidime and avibactam sodium for injection may inject new impetus into the treatment of drug-resistant bacteria in China .
-
Hengrui Medicine SHR-1906 injection was approved for clinical use
Time of Update: 2021-08-02
has recently received the approval of the National Medical Products Administration to issue the "Drug Clinical Trial Approval Notice" for SHR-1906 injection, and clinical trials will be launched in the near future .
-
Shenzhen builds "vegetable basket" and "rice bag" full chain collaboration mechanism
Time of Update: 2021-07-21
In the past year, in order to implement the "six stability and six guarantees", ensure food supply security and price stability, the Shenzhen Municipal Market Supervision Bureau actively planned the construction of the Haijixing "vegetable basket" town, and accelerated the research on the establishment of the "rice bag" and "vegetable basket" in Shenzhen.
-
Two Qilu injections have been reviewed
Time of Update: 2021-05-21
On May 10, the NMPA official website showed that Qilu Pharmaceutical's Decitabine for Injection and Cefminox Sodium for Injection passed the consistency evaluation.
At present, Qilu Pharmaceutical has 11 over-rated varieties entered into the fifth batch of collections, of which 9 varieties are injections.
-
The KHB-1802 project of Kanghong Pharmaceutical Conbercept ophthalmic injection is suspended in France
Time of Update: 2021-04-19
had recently received Agence nationale de sécurité du médicament et des produits de santé (French National Agency for the Safety of Medicines and Health Products, hereinafter referred to as ANSM) "A multi-center, double-blind, randomized, dose range trial to evaluate the efficacy and safety of Conbercept ophthalmic injection in the treatment of neovascular age-related macular degeneration" clinical trial project 2 ( KHB-1802) notice of suspension in France.
-
"Stock speculation" loss of 1.378 billion yuan Shanghai Lais "Blood King" status is difficult to protect
Time of Update: 2021-02-28
On February 22 this year, Shanghai Laix suspended trading on the grounds of restructuring, with a market capitalisation of 97.1 billion yuan, still ranking fourth in the A-share pharmaceutical industry.
According to the 2018 semi-annual report, Shanghai Laix' investment income was RMB1.37 billion and net profit was RMB855 million.
-
Assays of Nitrogenase Reaction Products
Time of Update: 2020-11-23
Steady-state assays of nitrogenases share at least five requirements: an anaerobic environment, a consistent source of magnesium adenosine triphosphate (MgATP), a suitable source of reductant, a buffer system compatible with the product-quantification protocol to be used, and the desired substrate.
-
BASF in Nanjing Chemical Park has added a production capacity of 20,000 tons of polyacrylamide
Time of Update: 2020-11-14
(BASF's polyacrylamide production facility in Nanjing Chemical Industrial Park has been completed and put into operation) Polyacrylamide Overview: Polyacrylamide (PAM) is a line polymer, the products are mainly divided into dry powder and collome two forms .
-
The country picks six passes, difficult to the green sky
Time of Update: 2020-07-12
Guide: The six customs of the national harvest come together Guanyun long over five pass cut six will walk a thousand miles alone riding, and the second development of national products from the pro
